Search Results 181-190 of 16780 for COPD

  1. Umeclidinium and vilanterol (inhalation route) - Side effects & dosage - Mayo Clinic

    Umeclidinium and vilanterol combination is used as maintenance treatment of air flow blockage in patients with chronic obstructive pulmonary disease (COPD).

  2. Medical Research & Education - Mayo Clinic News Network

    — Sleep data captured with a wearable device could help clinicians better tailor care by identifying patients with chronic obstructive pulmonary disease (COPD)[ ...

  3. Quit smoking, or don't start. Smoking is the leading cause of chronic obstructive pulmonary disease, also called COPD. If you have COPD, quitting can slow ...

  4. Budesonide, glycopyrrolate, and formoterol (inhalation route) - Side effects & dosage - Mayo Clinic

    Budesonide, glycopyrrolate, and formoterol combination is used as long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), including ...

  5. Evaluation Of The Spiration Valve For Emphysema To Improve Lung Function - Mayo Clinic

    ... COPD; Subject must be able to demonstrate physical ability to participate in the study by performing a 6-minute walk distance of ≥ 140 m; Subject has ...

  6. Evaluate The Effect Of Aclidinium Bromide On Long-term Cardiovascular Safety And Exacerbations In Moderate To Very Severe COPD Patients. - Mayo Clinic

    ... COPD exacerbations. This study is a double-blind, randomized, placebo ... COPD exacerbations in patients with moderate to very severe COPD, as defined ...

  7. Chronic bronchitis; COPD — (chronic obstructive pulmonary disease) — the blanket term for a group of diseases, including emphysema, that block airflow from the ...

  8. Shortness of breath When to see a doctor - Mayo Clinic

    Quit smoking, or don't start. Smoking is the leading cause of chronic obstructive pulmonary disease, also called COPD. If you have COPD, quitting can slow ...

  9. Umeclidinium (inhalation route) - Side effects & dosage - Mayo Clinic

    Umeclidinium is used to treat chronic obstructive pulmonary disease (COPD). This medicine will not relieve a COPD attack that has already started. Inhaled ...

  10. Multi-Center Study To Assess The Efficacy And Safety Of PT003, PT005, And PT001 In Subjects With Moderate To Very Severe COPD (PINNACLE 2) - Mayo Clinic

    Multi-Center Study To Assess The Efficacy And Safety Of PT003, PT005, And PT001 In Subjects With Moderate To Very Severe COPD (PINNACLE 2) · More about research ...